MSB 2.17% $1.42 mesoblast limited

Cell Therapy News/Articles, page-5611

  1. 5,491 Posts.
    lightbulb Created with Sketch. 8962
    Stem cell therapy ARM 1H20 report

    not sure if this has been posted here... it’s been shared on Twitter... and gives a nice summary of how the regenerative meds space is doing and how much activity is going on.

    second half edition will hopefully have us headline it
    Last edited by stockrock: 15/08/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.